Search Results (59)

Mental health agency buffeted by cuts - Tulsa World

Mental health agency buffeted by cuts Tulsa World Would "rainy day" fund or stimulus money stop the bleeding at hard-hit agencies? The answer is: some. But both of those sources are limited. ...

Health care: 2010 elections start here - The Swamp (blog)

New York Times

Health care: 2010 elections start here The Swamp (blog) For the Republicans, the midterms will be presented as a chance to retake at least part of Congress from a government trying to take over more than health ... Politics Today: The Health Care Bill's First Test in the Senate The Early Word: Health Bill Digest US Senate Test Vote On Health Bill Hits 60-Vote Threshhold  - -

'Stick with him,' Biden tells Iowans of Obama - DesMoinesRegister.com

Chippewa Herald

'Stick with him,' Biden tells Iowans of Obama DesMoinesRegister.com Biden defended the stimulus bill, a $787 billion spending package passed in February, intended to jumpstart the lagging economy. ... Register exclusive: Iowa Poll shows Obama approval rating below 50 percent

Activaero, GmbH: Series A $15.9M

Activaero (Germany) a commercial-stage medical device company focused on patient-tailored controlled breathing and inhaled therapeutic delivery systems, closed a $15.9M Series A financing. Participants include BioMedPartners, VI Partners, Abalis Finance and Vesalius Biocapital.

3Q09 OnBioVC | Trend Analysis Now Available

Hot off the press! The 3Q09 OnBioVC | Trend Analysis study is now available for download [HERE]. Over $1,663M flowed into early-stage biopharma, diagnostic and device companies in the third quarter of 2009 and over $4,806M year-to-date! If you find the information in OnBioVC to be of value kindly forward on to colleagues who you [...]

September 2009 OnBioVC | Trend Analysis Now Available

Hot off the press! The September 2009 OnBioVC | Trend Analysis study is now available for download [HERE]. Over $465M flowed into early-stage biopharma, diagnostic and device companies in the ninth month of 2009 and over $4,806M year-to-date! If you find the information in OnBioVC to be of value kindly forward on to colleagues who [...]

Celladon, Inc.: Series C $21.8M

Celladon (La Jolla, CA) a clinical-stage company focused on gene therapy for congestive heart failure, closed a $21.8M Series C financing. Participants include Enterprise Partners Venture Capital, Venrock and Johnson & Johnson Dev Corp.

Quanta Fluid Solutions, Ltd.: Series A $14.3M

Quanta Fluid Solutions (United Kingdom) a development-stage medical device company focused on haemodialysis systems for acute renal failure, has closed a $14.3M Series A financing. Participants include NBGI Ventures, Seroba Kernel Life Sciences, Wellington Partners Venture Capital and Brains-To-Ventures.